Cargando…

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms

INTRODUCTION: Neuroendocrine neoplasms (NEN) are heterogeneous malignancies that can arise at almost any anatomical site and are classified as biologically distinct well-differentiated neuroendocrine tumors (NET) and poorly differentiated neuroendocrine carcinomas (NEC). Current systemic therapies f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, James, Bergsland, Emily, Aggarwal, Rahul, Aparicio, Ana, Beltran, Himisha, Crabtree, Judy S, Hann, Christine L, Ibrahim, Toni, Byers, Lauren A, Sasano, Hironobu, Umejiego, John, Pavel, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632312/ https://www.ncbi.nlm.nih.gov/pubmed/35983951 http://dx.doi.org/10.1093/oncolo/oyac161

Ejemplares similares

Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy
por: Crabtree, Judy S.
Publicado: (2017)

Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020)

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues
por: Gallo, Marco, et al.
Publicado: (2021)

Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
por: Opalińska, Marta, et al.
Publicado: (2021)

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
por: Vitale, Giovanni, et al.
Publicado: (2021)

Neuroendocrine neoplasms in the breast oncology field: dilemmas of nature and morphology
por: Kawasaki, Tomonori, et al.
Publicado: (2023)

Epidemiologic trends and survival of early-onset gastroenteropancreatic neuroendocrine neoplasms
por: Yao, Hailing, et al.
Publicado: (2023)

Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
por: Giannetta, Elisa, et al.
Publicado: (2021)

Clinical and pathologic characteristics of appendiceal neuroendocrine neoplasms diagnosed during pregnancy
por: Twito, Orit, et al.
Publicado: (2023)

Natural History of Renal Neuroendocrine Neoplasms: A NET by Any Other Name?
por: Nguyen, Andrew H., et al.
Publicado: (2021)

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
por: Rudin, Charles M., et al.
Publicado: (2023)

Structured Reporting of Computed Tomography in the Staging of Neuroendocrine Neoplasms: A Delphi Consensus Proposal
por: Granata, Vincenza, et al.
Publicado: (2021)

Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms
por: Gao, Bingqiang, et al.
Publicado: (2021)

Multicenter Analysis of Presacral Neuroendocrine Neoplasms—Clinicopathological Characterization and Treatment Outcomes of a Rare Disease
por: Matrood, Sami, et al.
Publicado: (2021)

Multivisceral resection of nonfunctional pancreatic neuroendocrine neoplasm with nearby organ invasion: a case report
por: Zhang, Cong, et al.
Publicado: (2023)

The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014)

Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line
por: Bresciani, Giulia, et al.
Publicado: (2019)

Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment
por: Zhou, Yu-Jie, et al.
Publicado: (2021)

Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers
por: Giannetta, Elisa, et al.
Publicado: (2021)

Gender differences in pancreatic neuroendocrine neoplasms: A retrospective study based on the population of Hubei Province, China
por: Fu, Mengfei, et al.
Publicado: (2022)

Early-onset pancreatic neuroendocrine neoplasms: A distinct disease with improved survival compared with old individuals
por: Yang, Zhen, et al.
Publicado: (2023)

Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
por: Albertelli, Manuela, et al.
Publicado: (2021)

Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors
por: Crabtree, Judy S.
Publicado: (2022)

Phase Two Steroid Metabolism and Its Roles in Breast and Prostate Cancer Patients
por: McNamara, Keely M., et al.
Publicado: (2013)

Tumor Microenvironment in Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: Interaction between Tumors and Immune Cells, and Potential Effects of Neuroendocrine Differentiation on the Tumor Microenvironment
por: Tsunokake, Junichi, et al.
Publicado: (2022)

Outcomes after high-dose radiation in the management of neuroendocrine neoplasms
por: Chen, Katherine S., et al.
Publicado: (2021)

HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors
por: Liverani, Chiara, et al.
Publicado: (2023)

O(6)-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms
por: Watanabe, Hirofumi, et al.
Publicado: (2020)

Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation
por: Zhao, Fuqiang, et al.
Publicado: (2023)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Notch Signaling in Neuroendocrine Tumors
por: Crabtree, Judy S., et al.
Publicado: (2016)

Tumor Macroscopic Morphology Is an Important Prognostic Factor in Predicting Chemotherapeutic Efficacy and Clinical Outcomes of Patients With Colorectal Neuroendocrine Neoplasms, One Multicenter Retrospective Cohort Study
por: Wang, Zhijie, et al.
Publicado: (2021)

Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review
por: Ryzhkova, Daria, et al.
Publicado: (2022)

Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment
por: Busse, Antonia, et al.
Publicado: (2020)

Parietal Cell Dysfunction: A Rare Cause of Gastric Neuroendocrine Neoplasm with Achlorhydria and Extreme Hypergastrinemia
por: Abe, Yasuaki, et al.
Publicado: (2022)

Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity
por: Geenen, Vincent, et al.
Publicado: (2013)

Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
por: Bocchini, Martine, et al.
Publicado: (2020)

Neuroendocrine Role for VGF
por: Lewis, Jo E., et al.
Publicado: (2015)

Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
por: Geffers, Insa, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_57rlunf320ekj1rmpjqm1uuoej